搜尋結果

共 2162 個結果
頁數:1...50 51 52 53 54 55 56 57 58 ...109

Enhancing communication helps fight the epidemic

It has been a year since the COVID-19 outbreak. In January last year, John Hopkins University (the “University”) in the United States launched the world’s first COVID-19 interactive map dashboard, dis ...More

EJ Insight2021-02-18

Legco to review Covid-19 vaccine indemnity fund

The government is seeking HK$1 billion in funding from lawmakers to set up a Covid-19 vaccine indemnity fund. Chief Executive Carrie Lam first announced the plan in December last year. The fund aims a ...More

EJ Insight2021-02-18

Hong Kong people battle to adapt to Britain

In Hong Kong, the two Leungs earned a monthly income of more than HK$100,000 in managerial positions. Now they earn a tenth of that in their new life in Warrington, in the north of England, where they ...More

EJ Insight2021-02-18

「不止人類」的公共衞生

說到公共衞生的政治,當下有疫苗開發和分配的問題,也有隔離、電子監控等防疫政策與國家權力的問題。除了國家與資本, ...全文

今日信報時事評論文化論政馮蘊妍2021年02月18日

購疫苗遇挫 陳時中稱有人阻撓

台灣疫情指揮中心指揮官陳時中昨首度證實,早在去年就和德國BioNTech公司直接洽購500萬劑新冠疫苗(美國輝 ...全文

今日信報兩岸消息2021年02月18日

Hong Kong people battle to adapt to Britain

In Hong Kong, the two Leungs earned a monthly income of ...全文

今日信報時事評論EJ InsightMark O’Neill2021年02月18日

All work and no play makes Carrie a dull official

One of the golden rules in the workplace that has dominated for more than 300 years is: "All work and no play makes Jack a dull boy". Although we do not have a government official named Jack, we have ...More

EJ Insight2021-02-17

Pandemic restrictions to be eased, at last

From Thursday, some of the social distancing rules for catering and other businesses will be relaxed as the Covid-19 situation has improved, Secretary for Food & Health Sophia Chan said Tuesday. R ...More

EJ Insight2021-02-17

RCEP: A major driver to boost the Chinese and regional economy

COVID-19 pandemic not only brought about an overall global economic slump, but also wreaked havoc on daily life and upended day-to-day business operations, particular in supply chains. However, a silv ...More

EJ Insight2021-02-17

英國疫苗注射成功

10天在家檢疫完畢,恢復自由身的第一天剛好是年初一,做完瑜伽後決定開車去Croydon榮業行。去榮業超市買菜其 ...全文

今日信報副刊文化酒食浪遊劉群章2021年02月17日

恩恤探訪之兩難

香港政府於2020年1月25日提升全港應變級別至「緊急」。在「緊急應變級別」之下,所有公立醫院病房都要謝絕探病 ...全文

今日信報副刊文化醫者之言天峯醫生2021年02月17日

星斥逾640億抗疫 助民眾及企業渡難關

新加坡去年經濟收縮5.4%,略優於預估,但環球仍面臨疫情大流行打擊,當地經濟復甦之路充滿挑戰,政府在2021財 ...全文

即時新聞國際財經2021年02月16日

華為5G在東盟的發展

2020年美國繼續向各國施壓,呼籲禁用華為5G技術。例如,英國原本決定採用華為,但首相約翰遜承認因為美國施壓而 ...全文

今日信報時事評論黃伯農2021年02月16日

Contact-tracing app mandatory for govt buildings from March

Staff and visitors will be required to use the government’s contact-tracing app LeaveHomeSafe or register their personal information before entering government buildings from the beginning of next mon ...More

EJ Insight2021-02-11

Reflections on a plague year

It is probably premature to offer an assessment of the COVID-19 pandemic’s possible consequences, not least because there may well be many more twists and turns to come. And once we defeat the coronav ...More

EJ Insight2021-02-11

大華繼顯:恒指千點區間上落,醫藥新股後有來者

技術走勢:續在保力加通道的上通道運行,上試30,200點阻力焦點行業板塊:新股賽生藥業增長穩定但想像空間較低, ...影片

信報視頻宏觀視野2021年02月10日

君實生物(01877) 海外監管公告-業務發展最新情況

君實生物(01877) 海外監管公告 - 上海君實生物醫藥科技股份有限公司自願披露Etesevimab (JS ...全文

即時新聞港交所通告2021年02月10日

君實生物(01877) 內幕消息

君實生物(01877) 內幕消息-ETESEVIMAB (JS016)及BAMLANIVIMAB獲得FDA緊急 ...全文

即時新聞港交所通告2021年02月10日

Sustainability and active ownership in post-COVID-19 era

As COVID-19 provided much cause for pause panic throughout 2020, with markets whipsawing in response to economic recovery, vaccine and immunity hopes in the New Year, the job of analysts assessing lon ...More

EJ Insight2021-02-10

檢疫必要時的權利

離開女兒家去機場,出門口時孫女與我都哭得梨花帶雨。在路上一直想,為什麼總不能逃避愛的牽絆,幾多個靜修營之後,仍 ...全文

今日信報副刊文化酒食浪遊劉群章2021年02月10日

頁數:1...50 51 52 53 54 55 56 57 58 ...109

信報簡介 | 服務條款 | 私隱條款 | 免責聲明 | 廣告查詢 | 加入信報 | 聯絡信報

股票及指數資料由財經智珠網有限公司提供。期貨指數資料由天滙財經有限公司提供。外滙及黃金報價由路透社提供。

本網站的內容概不構成任何投資意見,本網站內容亦並非就任何個別投資者的特定投資目標、財務狀況及個別需要而編製。投資者不應只按本網站內容進行投資。在作出任何投資決定前,投資者應考慮產品的特點、其本身的投資目標、可承受的風險程度及其他因素,並適當地尋求獨立的財務及專業意見。本網站及其資訊供應商竭力提供準確而可靠的資料,但並不保證資料絕對無誤,資料如有錯漏而令閣下蒙受損失,本公司概不負責。